Table 4.
Methods | Positive EQA | Negative EQA | Sensitivity (%) | Specificity (%) | PPV (%) | NPV (%) | ||
---|---|---|---|---|---|---|---|---|
P. falciparum | Real time PCR | Positive | 8 | 0 | 73 ± 26 | 100 ± 25 | 73 ± 26 | 100 ± 25 |
Negative | 3 | 12 | ||||||
Total | 11 | 12 | ||||||
P. vivax | Positive | 6 | 0 | 100 ± 50 | 100 ± 25 | 100 ± 50 | 100 ± 25 | |
Negative | 0 | 12 | ||||||
Total | 6 | 12 | ||||||
P. malariae | Positive | 3 | 0 | 43 ± 37 | 100 ± 25 | 43 ± 37 | 100 ± 25 | |
Negative | 4 | 12 | ||||||
Total | 7 | 12 | ||||||
P. ovale | Positive | 4 | 0 | 100 ± 75 | 100 ± 25 | 100 ± 75 | 100 ± 25 | |
Negative | 0 | 12 | ||||||
Total | 4 | 12 | ||||||
P. knowlesi | Positive | 3 | 0 | 100 ± 100 | 100 ± 25 | 100 ± 100 | 100 ± 25 | |
Negative | 0 | 12 | ||||||
Total | 3 | 12 |
EQA External Quality Assessment, NPV negative predictive value, PPV positive predictive value. Parasitemia of the positive samples: P. falciparum from 0.2 to 1.1 106 p/µl, P. vivax from 5 to 400 p/µl, P. malariae from 2.3 to 800 p/µl, P. ovale from 20 to 280 p/µl and P. knowlesi from 2 to 20 p/µl.